{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Myasthenia Gravis: Christopher Klein, M.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/70571d2f\"></iframe>","width":"100%","height":180,"duration":1099,"description":"Christopher Klein, M.D., discusses how Mayo Clinic's updated, streamlined approach to confirmatory testing for the neuro immunological disorders myasthenia gravis and Lambert-Eaton Syndrome improves diagnostic accuracy. The testing method, a multi-step serology assay that automatically reflexes to second-line MuSK testing in cases where first-line serology is negative, increases sensitivity, specificity and yields 45% fewer false positives than traditional testing. Increasing accuracy of diagnostic confirmatory testing not only saves physicians' and patients' time, but optimizes treatment outcomes by minimizing unnecessary CT imaging and avoidable immunotherapy and thymectomy. ","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}